USC cardiology chief Saxon: 'People are using their phones for everything except their own health. We aim to change that.'

July 16, 2012 by Sony Salzman

MassDevice discusses medical devices for mobile phones and the future of networked patient care with Dr. Leslie Saxon, cardiology chief at the University of Southern California.

MassDevice.com news

As cardiology chief of the Keck School of Medicine at the University of Southern California, Dr. Leslie Saxon is spearheading a successful mobile health innovation center called the Center for Body Computing. Founded in 2010, the coalition works with engineers, device companies and thought leaders to develop mobile health software and apps.

Saxon's ultimate goal is to create a single platform that is the "epicenter of wireless health." The CBC has developed working relationships with device companies and innovators including Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX) and St. Jude Medical (NYSE:STJ). She also hosts an annual Body Computing Conference, which brings together cross-disciplinary leaders from medicine, design, gaming and pharmaceuticals.

Sign up to get our free newsletters delivered straight to your inbox

The goal of all this collaboration is a “Facebook for healthcare," where patients, doctors and manufacturers share data in a dynamic online space. With more than 5 billion people wielding mobile devices, Saxon believes it's time to re-think the way healthcare is consumed. MassDevice.com caught up with Saxon to discuss her vision for the future of mHealth.

MassDevice: How does the Center for Body Computing find fresh new ideas to develop?

Comments

Features

Calhoun Vision CEO Verne Sharma tells MassDevice.com why his company's light-adjustable lens will disrupt the practice of ophthalmology.

Kevin King, CEO of Silicon Valley digital health company iRhythm, tells MassDevice about the promise of Big Data and how remote patient monitoring can reveal intricate details of the habits of the heart.

Covidien's Stacy Enxing Seng speaks to MassDevice.com about the Medtronic merger during our DeviceTalks Minnesota event.

The FDA is ramping up its cybersecurity labs and may start rejecting insecure technologies sooner than you think.

Transcend Medical CEO Brian Walsh tells MassDevice.com why his company's CyPass micro-stent is poised to revolutionize the treatment of glaucoma.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp